Loading clinical trials...
Loading clinical trials...
The purpose of this study is to characterize the natural history of leukocyte chemotactic factor 2 amyloidotic (ALECT2) disease. In this observational study participants with ALECT2 disease will be en...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alnylam Pharmaceuticals
NCT06563895 · Amyloidosis, Amyloid Cardiomyopathy, and more
NCT07266116 · Systemic Light Chain Amyloidosis
NCT06465810 · Transthyretin Amyloidosis, ATTR-CM, and more
NCT07358078 · Transthyretin Amyloidosis With Cardiomyopathy
NCT06355934 · ATTR Amyloidosis
Clinical Trial Site
Scottsdale, Arizona
Clinical Trial Site
Tucson, Arizona
Clinical Trial Site
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions